Renal failure and liver transplantation

Clinical Liver Disease

Volumn 2, Issue 3, 2013, Pages 106-108

  Boyer, Thomas D ^a   Kaplan, Bruce ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALBUMIN; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PLACEBO; RAPAMYCIN; TACROLIMUS; TERLIPRESSIN; TRIMETHOPRIM;

ACUTE GLOMERULONEPHRITIS; ACUTE KIDNEY TUBULE NECROSIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL PERITONITIS; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DRUG INDUCED DISEASE; HEPATITIS B; HEPATITIS C; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; HYPOVOLEMIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INFECTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; DRUG EFFECT; KIDNEY DYSFUNCTION; REVIEW; SURVIVAL;

EID: 84940279481     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.170     Document Type: Article

References (12)

1. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008; 48: 2064-2077.
2. Lim Y-S, Larson TS, Benson JT, Kamath PS, Kremers W, Therneau TM, et al. Serum sodium, renal function, and survival of patients with end-stage live disease. J Hepatol 2010; 52: 523-528.
3. Fabrizi F, Dixit V, Martin P, Messa P. Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies. Dig Dis Sci 2011; 56: 1282-1289.
4. Sanyal AK, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, et al. A randomized, prospective, double blind, placebo-controlled study of terlipressin for type I hepatorenal syndrome. Gastroenterology 2008: 134: 1360- 1368.
5. Martin-Llahi M, Pepin MN, Guevara M, Diaz F, Torre A, Monescillo A, et al. Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008; 134: 1352-1359.
6. Boyer TD, Sanyal AJ, Garcia-Tsao G, Regenstein F, Rossaro L, et al. Impact of liver transplantation on survival of patients treated for type 1 hepatorenal syndrome. Liver Transpl 2011: 17; 1328- 1332.
7. Rice JP, Skagen C, Said A. Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin. Transplantation 2011; 91: 1141- 1147.
8. Northrup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH. Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl 2010; 16: 440-446.
9. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transpl 2008; 2243- 2251.
10. Martin EF, Huang J, Xiang Q, Klein JP, Bajaj J, Saelan K. Recipeint survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the United Network for Organ Sharing Database. Liver Transpl 2012; 18: 914-929.
11. Naesens M, Kuypers D, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481-508.
12. Stallone G, Infante B, Pontrelli P, Gigante M, Montemurno E, Loverre A, et al. Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins. Transplantation 2011; 91: 997-1004.